nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
|
Hahn, Andrew W. |
|
2019 |
3 |
1 |
p. 7-13 |
artikel |
2 |
Clinical Trials Corner
|
Parikh, Mamta |
|
2019 |
3 |
1 |
p. 79-80 |
artikel |
3 |
Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review
|
Achkar, Tala |
|
2019 |
3 |
1 |
p. 31-40 |
artikel |
4 |
Radiation Therapy for Renal Cell Carcinoma
|
Choi, Rachel |
|
2019 |
3 |
1 |
p. 1-6 |
artikel |
5 |
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib – Results of NCI/CTEP Protocol 9048
|
Semrad, Thomas J |
|
2019 |
3 |
1 |
p. 51-61 |
artikel |
6 |
Real-World Outcome of 173 Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC) Cases: The Experience of the Center Group for Genitourinary Tumors
|
Martín, Almudena |
|
2019 |
3 |
1 |
p. 41-50 |
artikel |
7 |
Stereotactic Body Radiation Therapy for Renal Cell Carcinoma with Inferior Vena Cava Thrombus – Initial Experience Report and Literature Review
|
Freifeld, Yuval |
|
2019 |
3 |
1 |
p. 71-77 |
artikel |
8 |
Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
|
Bergerot, Paulo Gustavo |
|
2019 |
3 |
1 |
p. 63-70 |
artikel |
9 |
The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
|
Hoerner, Christian R. |
|
2019 |
3 |
1 |
p. 15-29 |
artikel |